Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial introductions91
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?89
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review69
Genetic determinants of plasma lipids in Greenlanders55
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease44
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism39
Genetic variation in apolipoprotein A-V in hypertriglyceridemia36
Polygenic risk scores in familial hypercholesterolemia. Do they have a role?31
Alveolar macrophages: guardians of the alveolar lipid galaxy27
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases21
Implementation science and genetic testing for familial hypercholesterolemia21
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances20
Familial hypercholesterolemia in children and the importance of early treatment20
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1920
Oxidized LDL receptors: a recent update20
Lipid metabolism during pregnancy: consequences for mother and child20
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?19
Editorial introductions19
Exosomes and lipid metabolism in metabolic and cardiovascular disorders19
Nonalcoholic fatty liver disease: an update17
Nutrition and its impact on cardiovascular disease17
Recent advances in understanding the spectrum of genetic determinants of lipoprotein(a) levels16
A new SPRING in lipid metabolism15
Familial hypercholesterolemia in pregnancy15
Genetic determinants of pancreatitis risk in hypertriglyceridemia15
Editorial introductions14
The current state of apolipoprotein E in dyslipidemia14
From clinical development to real-world outcomes with inclisiran14
The need for national and international registries of patients with elevated lipoprotein(a)13
Genetic insights from Greenland: when geography, history and genomics converge13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets13
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?13
Can small dense LDL cholesterol be estimated from the lipid profile?12
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion12
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?12
Evolving guidelines on lipoprotein(a)12
APOE and familial hypercholesterolemia12
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent11
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis11
Editorial introductions11
Beyond cholesterol: linking the conformation of apolipoprotein B to atherogenesis10
Newborn screening for lipid disorders10
In the wake of the Scandinavian Simvastatin Survival Study trial10
Cardiomyocytes, sphingolipids and cardio myotoxicity10
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review9
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease9
Pregnancy, cardiovascular health, and microchimerism9
Distinct roles of size-defined HDL subpopulations in cardiovascular disease9
0.11330795288086